Sign inJoin waitlistJoin the waitlist

Back to Stanford Health Care-Sponsored Stanford University Internal Medicine

Ronald Witteles

Program Director, Internal Medicine Residency · Stanford Health Care

Credentials: ·

History

Internal Medicine Residency · Stanford Health Care
Present

Research

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
New England Journal of Medicine · 2018 · 2,246 citations
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Annals of Oncology · 2020 · 761 citations
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the…
European Journal of Heart Failure · 2020 · 646 citations

Mathew Maurer
23 papers
Michaela Liedtke
20 papers
Kevin Alexander
19 papers · 9 as a fellow
Han Zhu
17 papers · 5 as a fellow
Martha Grogan
17 papers
Sarah Waliany
16 papers · 15 as a resident
Paul Cheng
15 papers
Mazen Hanna
14 papers
Joel Neal
12 papers
Sally Arai
12 papers
Stanley Schrier
12 papers
Michael Fowler
11 papers

Grants

Identification of Druggable Targets for Cancer Therapy-Induced Cardiotoxicity
National Heart, Lung, and Blood Institute · R01
PI · $770.6K · Stanford University
2026–2030

Clinical trials

Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation
Principal investigator · Completed · Phase 1
Ronald Witteles
2021–2024
Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation
Principal investigator · Withdrawn · Phase 1
Ronald Witteles
2021–2023
Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients With Heart Failure
Study director · Completed · Early phase 1
Stanford University
2008–2012
BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
Study director · Completed · Phase 4
Stanford University
2004–2006